Last reviewed · How we verify
Desogestrel early follicular phase
Desogestrel early follicular phase is a Progestin (hormonal contraceptive) Small molecule drug developed by Centre Hospitalier Intercommunal Creteil. It is currently in Phase 3 development for Contraception (pregnancy prevention).
Desogestrel is a progestin that prevents pregnancy by suppressing ovulation and altering cervical mucus and endometrial conditions.
Desogestrel is a progestin that prevents pregnancy by suppressing ovulation and altering cervical mucus and endometrial conditions. Used for Contraception (pregnancy prevention).
At a glance
| Generic name | Desogestrel early follicular phase |
|---|---|
| Sponsor | Centre Hospitalier Intercommunal Creteil |
| Drug class | Progestin (hormonal contraceptive) |
| Target | Progesterone receptor |
| Modality | Small molecule |
| Therapeutic area | Contraception / Reproductive Health |
| Phase | Phase 3 |
Mechanism of action
Desogestrel is a third-generation synthetic progestin used in hormonal contraceptives. It works primarily by inhibiting the luteinizing hormone (LH) surge needed to trigger ovulation. Additionally, it increases cervical mucus viscosity to impede sperm penetration and alters the endometrium to reduce implantation likelihood. The early follicular phase formulation is part of a biphasic or multiphasic oral contraceptive regimen.
Approved indications
- Contraception (pregnancy prevention)
Common side effects
- Nausea
- Headache
- Breast tenderness
- Breakthrough bleeding
- Mood changes
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Desogestrel early follicular phase CI brief — competitive landscape report
- Desogestrel early follicular phase updates RSS · CI watch RSS
- Centre Hospitalier Intercommunal Creteil portfolio CI
Frequently asked questions about Desogestrel early follicular phase
What is Desogestrel early follicular phase?
How does Desogestrel early follicular phase work?
What is Desogestrel early follicular phase used for?
Who makes Desogestrel early follicular phase?
What drug class is Desogestrel early follicular phase in?
What development phase is Desogestrel early follicular phase in?
What are the side effects of Desogestrel early follicular phase?
What does Desogestrel early follicular phase target?
Related
- Drug class: All Progestin (hormonal contraceptive) drugs
- Target: All drugs targeting Progesterone receptor
- Manufacturer: Centre Hospitalier Intercommunal Creteil — full pipeline
- Therapeutic area: All drugs in Contraception / Reproductive Health
- Indication: Drugs for Contraception (pregnancy prevention)
- Compare: Desogestrel early follicular phase vs similar drugs
- Pricing: Desogestrel early follicular phase cost, discount & access